801 related articles for article (PubMed ID: 11177538)
1. Retrovector encoding a green fluorescent protein-herpes simplex virus thymidine kinase fusion protein serves as a versatile suicide/reporter for cell and gene therapy applications.
Paquin A; Jaalouk DE; Galipeau J
Hum Gene Ther; 2001 Jan; 12(1):13-23. PubMed ID: 11177538
[TBL] [Abstract][Full Text] [Related]
2. Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer.
Galipeau J; Li H; Paquin A; Sicilia F; Karpati G; Nalbantoglu J
Cancer Res; 1999 May; 59(10):2384-94. PubMed ID: 10344748
[TBL] [Abstract][Full Text] [Related]
3. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir.
Howard BD; Boenicke L; Schniewind B; Henne-Bruns D; Kalthoff H
Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025
[TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus thymidine kinase-green fluorescent protein fusion gene: new tool for gene transfer studies and gene therapy.
Loimas S; Wahlfors J; Jänne J
Biotechniques; 1998 Apr; 24(4):614-8. PubMed ID: 9564534
[TBL] [Abstract][Full Text] [Related]
5. Delivery of herpes simplex thymidine kinase bystander effect by engineered human mesothelial cells for the treatment of ovarian cancer.
Rancourt C; Bergeron C; Lane D; Garon G; Piché A
Cytotherapy; 2003; 5(6):509-22. PubMed ID: 14660047
[TBL] [Abstract][Full Text] [Related]
6. TK-GFP fusion gene virus vectors as tools for studying the features of HSV-TK/ganciclovir cancer gene therapy in vivo.
Pasanen T; Hakkarainen T; Timonen P; Parkkinen J; Tenhunen A; Loimas S; Wahlfors J
Int J Mol Med; 2003 Oct; 12(4):525-31. PubMed ID: 12964030
[TBL] [Abstract][Full Text] [Related]
7. Bystander-mediated regression of osteosarcoma via retroviral transfer of the herpes simplex virus thymidine kinase and human interleukin-2 genes.
Walling HW; Swarthout JT; Culver KW
Cancer Gene Ther; 2000 Feb; 7(2):187-96. PubMed ID: 10770626
[TBL] [Abstract][Full Text] [Related]
8. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R
Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095
[TBL] [Abstract][Full Text] [Related]
9. Abnormal expression of only the CD34 part of a transgenic CD34/herpes simplex virus-thymidine kinase fusion protein is associated with ganciclovir resistance.
Bennour E; Ferrand C; Rémy-Martin JP; Certoux JM; Gorke S; Qasim W; Gaspar HB; Baumert T; Duperrier A; Deschamps M; Fehse B; Tiberghien P; Robinet E
Hum Gene Ther; 2008 Jul; 19(7):699-709. PubMed ID: 18557699
[TBL] [Abstract][Full Text] [Related]
10. [Vesicular stomatitis virus G-protein retrovector mediated a herpes simplex virus thymidine kinase gene transduction and expression in the human retinal pigment epithelial cells].
Wang F; Wang HW; Lu DR; Xue JL; Zhang X
Zhonghua Yan Ke Za Zhi; 2003 Apr; 39(4):201-5. PubMed ID: 12882696
[TBL] [Abstract][Full Text] [Related]
11. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
12. Functional coexpression of HSV-1 thymidine kinase and green fluorescent protein: implications for noninvasive imaging of transgene expression.
Jacobs A; Dubrovin M; Hewett J; Sena-Esteves M; Tan CW; Slack M; Sadelain M; Breakefield XO; Tjuvajev JG
Neoplasia; 1999 Jun; 1(2):154-61. PubMed ID: 10933050
[TBL] [Abstract][Full Text] [Related]
13. Suppression of murine mammary carcinoma growth and metastasis by HSVtk/GCV gene therapy using in vivo electroporation.
Shibata MA; Morimoto J; Otsuki Y
Cancer Gene Ther; 2002 Jan; 9(1):16-27. PubMed ID: 11916241
[TBL] [Abstract][Full Text] [Related]
14. Hepatoma cell-specific ganciclovir-mediated toxicity of a lentivirally transduced HSV-TkEGFP fusion protein gene placed under the control of rat alpha-fetoprotein gene regulatory sequences.
Uch R; Gérolami R; Faivre J; Hardwigsen J; Mathieu S; Mannoni P; Bagnis C
Cancer Gene Ther; 2003 Sep; 10(9):689-95. PubMed ID: 12944988
[TBL] [Abstract][Full Text] [Related]
15. Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors.
Ram Z; Culver KW; Walbridge S; Frank JA; Blaese RM; Oldfield EH
J Neurosurg; 1993 Sep; 79(3):400-7. PubMed ID: 8395592
[TBL] [Abstract][Full Text] [Related]
16. Use of a herpes thymidine kinase/neomycin phosphotransferase chimeric gene for metabolic suicide gene transfer.
Candotti F; Agbaria R; Mullen CA; Touraine R; Balzarini J; Johns DG; Blaese RM
Cancer Gene Ther; 2000 Apr; 7(4):574-80. PubMed ID: 10811475
[TBL] [Abstract][Full Text] [Related]
17. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
Ram Z; Culver KW; Walbridge S; Blaese RM; Oldfield EH
Cancer Res; 1993 Jan; 53(1):83-8. PubMed ID: 8380127
[TBL] [Abstract][Full Text] [Related]
18. VP22 does not significantly enhance enzyme prodrug cancer gene therapy as a part of a VP22-HSVTk-GFP triple fusion construct.
Hakkarainen T; Wahlfors T; Meriläinen O; Loimas S; Hemminki A; Wahlfors J
J Gene Med; 2005 Jul; 7(7):898-907. PubMed ID: 15759279
[TBL] [Abstract][Full Text] [Related]
19. Green fluorescent protein retroviral vectors: low titer and high recombination frequency suggest a selective disadvantage.
Hanazono Y; Yu JM; Dunbar CE; Emmons RV
Hum Gene Ther; 1997 Jul; 8(11):1313-9. PubMed ID: 9295126
[TBL] [Abstract][Full Text] [Related]
20. Generation of fusion genes carrying drug resistance, green fluorescent protein, and herpes simplex virus thymidine kinase genes in a single cistron.
Oh SC; Nam SY; Kwon HC; Kim CM; Seo JS; Seong RH; Jang YJ; Chung YH; Chung HY
Mol Cells; 2001 Apr; 11(2):192-7. PubMed ID: 11355700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]